MyFinsight
Home
About
Contact
avbp: the income statement
Download
Download image
Unrealized gain on
marketable securities
$226K
Total comprehensive
loss
-$34,752K
Total other
comprehensive gain
$226K
Net loss
-$34,978K
Interest and investment
income
$3,338K
Operating loss
-$38,316K
Total operating
expenses
$38,316K
General and
administrative
$6,149K
Research and development
$32,167K
Back
Back
Income Statement
source: myfinsight.com
ArriVent BioPharma, Inc. (AVBP)
ArriVent BioPharma, Inc. (AVBP)